Symplicity G3
Device Renal Denervation System
PDI 00643169615984
General payments
$3,013,212
Research payments
$32,734,141
Through program year 2025, $3,013,212 in general payments and $32,734,141 in research payments were reported against Symplicity G3 (Renal Denervation System).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,126,295 | 13,222 |
| 2025 | Research | $12,426,900 | 730 |
| 2024 | General | $820,750 | 7,718 |
| 2024 | Research | $16,566,101 | 693 |
| 2023 | General | $66,167 | 428 |
| 2023 | Research | $3,741,140 | 507 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 84 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
21,368 general · 1,930 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.